Delivery Order SPE2DB20D3103-SPE2DB25FN0S9
Award Date
3/14/25
Potential Completion Date
4/4/25
Potential Value
$80K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,750.80 firm fixed-price delivery order is for the supply of 4,566,658,071 units of the medication NovoSeven RT 5 mg vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $82,935.48 firm-fixed-price contract is for the supply of NovoSeven RT 5 mg vials, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,900.96 Firm Fixed Price delivery order contract is for the supply of NovoSeven RT 5 mg vials, a specialty medication. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $50,818.95, is for the supply of NovoSeven RT 5 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovoSeven RT 5 mg vials. The contract, valued at $6,911.29, is a firm fixed-price delivery order with an ultimate completion date of September 12, 2024. There is no set-aside designation for this award. Amerisourcebergen, through its Corporate Office division, will provide this critical medication to support various federal healthcare...
This is a delivery order award under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of NovoSeven RT 5 mg vials, a critical specialty medication. The award has a ceiling value of $27,605.04 and a period of performance through March 17, 2025. This IDC provides a comprehensive contracting mechanism for the DLA to procure a wide range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $27,604.30 order is for the supply of NOVOSEVEN RT 2 MG VIALS, a specialized pharmaceutical product. The delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and...
This federal contract award, valued at $33,377.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of NovaSeven RT 5 mg vials, a specialty pharmaceutical product. This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. The IDC serves as a primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOSEVEN RT 2 MG VIALS. The contract has a potential value of $21,675.92 and a performance completion date of January 12, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in...
The Defense Logistics Agency awarded a $5,418.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561309677 NovoSeven RT 2 mg vials. The contract has a period of performance from June 21, 2023 through July 13, 2023 and will be performed in Conshohocken, Pennsylvania. NovoSeven is a recombinant factor VIIa product used to treat bleeding episodes in patients with hemophilia A or B with inhibitors. The Defense Logistics Agency manages the Department of Defense's global...